New Key Statistics Module, Z-Score and F-Score
SZSE:002262 Key Ratios
Market Cap ¥ M | 27,690.82 |
Enterprise Value ¥ M | 24,308.59 |
P/E(ttm) | 24.55 |
PE Ratio without NRI | 23.74 |
Forward PE Ratio | 18.92 |
Price/Book | 4.07 |
Price/Sales | 5.10 |
Price/Free Cash Flow | 36.54 |
Price/Owner Earnings | 31.27 |
Payout Ratio % | 0.28 |
Revenue (TTM) ¥ M | 5,404.00 |
EPS (TTM) ¥ | 1.11 |
Beneish M-Score | -2.24 |
10-y EBITDA Growth Rate % | 18.10 |
5-y EBITDA Growth Rate % | 12.50 |
y-y EBITDA Growth Rate % | 14.50 |
EV-to-EBIT | 17.31 |
EV-to-EBITDA | 17.31 |
PEG | 1.90 |
Shares Outstanding M | 1,016.18 |
Net Margin (%) | 20.74 |
Operating Margin % | 23.33 |
Pre-tax Margin (%) | 23.46 |
Quick Ratio | 5.95 |
Current Ratio | 6.62 |
ROA % (ttm) | 15.34 |
ROE % (ttm) | 17.44 |
ROIC % (ttm) | 34.95 |
Dividend Yield % | 1.17 |
Altman Z-Score | 19.35 |
SZSE:002262 Number of Guru Trades
SZSE:002262 Volume of Guru Trades
Gurus Latest Trades with SZSE:002262
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002262 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jiangsu Nhwa Pharmaceutical Co Ltd Insider Transactions
No Available Data